000			01943naa a2200193uu 4500
001			0042614395737
003			OSt
005			20190211171214.0
008			100426s2009 xx ||||gr |0|| 0 eng d
100	1		_aAGGARWAL, Vikas A. _939668
245	1	0	_aModes of corporative R&D commercialization by start-ups
260			_aBognor Regis : _bWiley-Blackwell, _cAugust 2009
520	3		_aThis study empirically examines the determinants of heterogeneous firm-level cooperative R&D commercialization strategies. While the volume of interfirm collaboration has increased dramatically in recent decades, the determinants of firm-level choices among alternate modes of such cooperative activity remain relatively understudied. We develop a conceptual model of factors determining collaborative mode choice at the organizational portfolio level. These factors include the firm-level appropriation environment, in which deal-level choices have portfolio-level spillover implications, as well as governance capabilities developed by the firm over time. Using a random sample of innovating biotechnology start-ups, we assemble a firm-year panel dataset that aggregates transaction-level collaboration data to the firm-year level, allowing us to characterize firms' portfolios of collaborative deals. We find broad empirical support for our model, suggesting that a firm's appropriation environment and governance capabilities strongly influence portfolio-level collaboration mode choices. In addition, we explore the implications of governance capability development, finding that experience with particular modes, as well as deviations from existing capabilities, impact firm valuation.
700	1		_aHSU, David H. _939669
773	0	8	_tStrategic Management Journal _g30, 8, p. 835-864 _dBognor Regis : Wiley-Blackwell, August 2009 _xISSN 01432095 _w
942			_cS
998			_a20100426 _b1439^b _cDaiane
998			_a20100428 _b1701^b _cCarolina
999			_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c32588 _d32588
041			_aeng